Henry Yang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 1%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
Papers in
-
- RNA Research and Splicing 30
- RNA modifications and cancer 29
- Epigenetics and DNA Methylation 25
- Pluripotent Stem Cells Research 21
- CRISPR and Genetic Engineering 18
- RNA regulation and disease 13
- Cancer-related gene regulation 12
- Genomics and Chromatin Dynamics 12
- Co-authors
- Bing Lim (14 shared papers)Kian Leong Lee (14 shared papers)Lorenz Poellinger (12 shared papers)Urban Lendahl (2 shared papers)H. Phillip Koeffler (30 shared papers)Wai Leong Tam (7 shared papers)Daniel G. Tenen (18 shared papers)Huck‐Hui Ng (4 shared papers)
- Journals
- Nature Communications (12 papers)Blood (8 papers)Cancer Research (8 papers)Nucleic Acids Research (7 papers)Oncogene (6 papers)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Henry Yang
166 papers receiving 9.1k citations
Henry Yang's Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 1.9k
- Molecular Biology 5.7k
- Immunology 1.5k
- Hematology 646
- Oncology 1.4k
Countries citing papers authored by Henry Yang
This map shows the geographic impact of Henry Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Yang more than expected).
Fields of papers citing papers by Henry Yang
This network shows the impact of papers produced by Henry Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Yang. The network helps show where Henry Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade Hit paper breakdown → | 2018 | 480 |
| 2 | 2010 | 416 | |
| 3 | 2015 | 326 | |
| 4 | 2011 | 290 | |
| 5 | 2009 | 283 | |
| 6 | 2005 | 276 | |
| 7 | 2009 | 241 | |
| 8 | 2010 | 239 | |
| 9 | 2014 | 223 | |
| 10 | 2013 | 205 | |
| 11 | 2007 | 198 | |
| 12 | 2008 | 187 | |
| 13 | 2007 | 180 | |
| 14 | 2015 | 176 | |
| 15 | 2016 | 172 | |
| 16 | 2014 | 162 | |
| 17 | 2012 | 156 | |
| 18 | 2008 | 154 | |
| 19 | 2018 | 144 | |
| 20 | Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. | 2012 | 134 |
About Henry Yang
Henry Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Hematology and Immunology, having authored 170 papers that have together received 9.2k indexed citations. Recurring topics across this work include RNA Research and Splicing (30 papers), RNA modifications and cancer (29 papers), Epigenetics and DNA Methylation (25 papers), Pluripotent Stem Cells Research (21 papers), CRISPR and Genetic Engineering (18 papers), RNA regulation and disease (13 papers), Cancer-related gene regulation (12 papers) and Genomics and Chromatin Dynamics (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (5.7k citations), Immunology (1.5k citations), Hematology (646 citations) and Oncology (1.4k citations). Henry Yang has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Bing Lim, Kian Leong Lee, Lorenz Poellinger, Urban Lendahl, H. Phillip Koeffler, Wai Leong Tam, Daniel G. Tenen, Huck‐Hui Ng, Meng Ling Choong and Ian McNiece. Their work appears in journals such as Nature Communications, Blood, Cancer Research, Nucleic Acids Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.